From watching the Ted talk, it is obvious Leronlimab is working very with Covid. If it was not, Dr Patterson would not be doing the talk at all, or any interviews. He sees the blood tests - he knows and there is no reason to think the results are not positive. What I'm interested in seeing is how this plays out in early July when the data from both Covid trials is compiled and given to the FDA. I don't think the public will get the news until the FDA responds and the data is then shown. I am not sure why the severe trial is a phase 2/3 and the M2M is phase 2 and I do not know why the # of trial participants is so different. We all hope the FDA sees the data and says approved on the spot, but I guess a possible set back would be needing more data or the data too be updated with other info?

The other worry I have is what will BP do to block or hurt our chances? I think the distribution partnership with a BP will go a long way to protecting us and not creating a david vs goliath situation. If BP actually jumps in and we get a partner that has every need to get this to market, we are going to have a very solid foundation to make this happen.In only approx.4 weeks it will be interesting.